Agency Information Collection Activities: Proposed Collection; Comment Request, 65404-65406 [2020-22837]
Download as PDF
<![CDATA[
65404
Federal Register / Vol. 85, No. 200 / Thursday, October 15, 2020 / Notices
Federal Communications
Commission, 445 12th Street SW,
Washington, DC 20554.
FOR FURTHER INFORMATION CONTACT:
Scott Marshall, Designated Federal
Officer, FCC Consumer Advisory
Committee, Consumer and
Governmental Affairs Bureau, Federal
Communications Commission, 445 12th
Street SW, Washington, DC 20554;
phone: 202–418–2809 (voice or Relay);
email: scott.marshall@fcc.gov; or
Gregory V. Haledjian, Deputy
Designated Federal Officer, FCC
Consumer Advisory Committee,
Consumer and Governmental Affairs
Bureau, Federal Communications
Commission, 445 12th Street SW,
Washington, DC 20554; phone: 202–
418–7440; email: gregory.haledjian@
fcc.gov.
ADDRESSES:
In
accordance with the Federal Advisory
Committee Act, Public Law 92–463, as
amended, this notice advises interested
persons that the GSA has approved the
renewal of the charter of the CAC for
two years, commencing October 16,
2020. In keeping with its advisory role,
the FCC Consumer Advisory Committee
will continue to provide
recommendations to the Commission on
consumer topics, as specified by the
Commission, gather data and
information, and perform analyses that
are necessary to respond to the
questions or matters before it.
SUPPLEMENTARY INFORMATION:
Federal Communications Commission.
Cecilia Sigmund,
Associate Secretary.
[FR Doc. 2020–22751 Filed 10–14–20; 8:45 am]
BILLING CODE P
FEDERAL ELECTION COMMISSION
Sunshine Act Meetings
Tuesday, October 20,
2020 at 10:00 a.m.
PLACE: 1050 First Street NE,
Washington, DC (This meeting will be a
virtual meeting).
STATUS: This meeting will be closed to
the public.
MATTERS TO BE CONSIDERED: Compliance
matters pursuant to 52 U.S.C. 30109.
Matters relating to internal personnel
decisions, or internal rules and
practices.
Investigatory records compiled for
law enforcement purposes and
production would disclose investigative
techniques.
Information the premature disclosure
of which would be likely to have a
considerable adverse effect on the
jbell on DSKJLSW7X2PROD with NOTICES
TIME AND DATE:
VerDate Sep<11>2014
17:41 Oct 14, 2020
Jkt 253001
implementation of a proposed
Commission action.
Matters concerning participation in
civil actions or proceedings or
arbitration.
*
*
*
*
*
CONTACT PERSON FOR MORE INFORMATION:
Judith Ingram, Press Officer. Telephone:
(202) 694–1220.
Vicktoria J. Allen,
Acting Deputy Secretary of the Commission.
[FR Doc. 2020–22991 Filed 10–13–20; 4:15 pm]
BILLING CODE 6715–01–P
FEDERAL MARITIME COMMISSION
Notice of Agreements Filed
The Commission hereby gives notice
of the filing of the following agreements
under the Shipping Act of 1984.
Interested parties may submit
comments, relevant information, or
documents regarding the agreements to
the Secretary by email at Secretary@
fmc.gov, or by mail, Federal Maritime
Commission, Washington, DC 20573.
Comments will be most helpful to the
Commission if received within 12 days
of the date this notice appears in the
Federal Register. Copies of agreements
are available through the Commission’s
website (www.fmc.gov) or by contacting
the Office of Agreements at (202) 523–
5793 or tradeanalysis@fmc.gov.
Agreement No.: 201350.
Agreement Name: King Ocean/
Seaboard St. Maarten Space Charter
Agreement.
Parties: King Ocean Services Limited,
Inc. and Seaboard Marine Ltd.
Filing Party: Wayne Rohde; Cozen
O’Connor.
Synopsis: The Agreement authorizes
King Ocean to charter space to Seaboard
in the trade between the U.S. and St.
Maarten.
Proposed Effective Date: 11/22/2020.
Location: https://www2.fmc.gov/
FMC.Agreements.Web/Public/
AgreementHistory/35502.
Dated: October 9, 2020.
Rachel E. Dickon,
Secretary.
[FR Doc. 2020–22812 Filed 10–14–20; 8:45 am]
BILLING CODE 6730–02–P
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project ‘‘Clinical
Decision Support (CDS) for Chronic
Pain Management.’’
This proposed information collection
was previously published in the Federal
Register on July 14, 2020 and allowed
60 days for public comment. AHRQ
received no substantive comments. The
purpose of this notice is to allow an
additional 30 days for public comment.
DATES: Comments on this notice must be
received within 30 days of publication
date.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Proposed Project
Clinical Decision Support (CDS) for
Chronic Pain Management
Prescription opioid pain medication
overuse, misuse, and abuse have been a
significant contributing factor in the
opioid epidemic. The goal of this project
is to develop, implement, disseminate,
and evaluate clinical decision support
(CDS) tools for both patients and
providers in the management of chronic
pain. The CDS tools are intended to be
interoperable and publicly-shareable
and will be designed to meet the needs
of patients and providers through both
patient-facing and provider-facing
channels and formats.
The development and deployment of
CDS tools designed to optimize opioid
dose reduction is intended to support
E:\FR\FM\15OCN1.SGM
15OCN1
65405
Federal Register / Vol. 85, No. 200 / Thursday, October 15, 2020 / Notices
primary care providers (including
physicians and advanced practice
providers) who are not painmanagement specialists as well as pain
specialists as they care for patients who
are at high risk of harm from opioids.
This goal will be achieved through the
design, development, implementation,
and evaluation of a provider-facing CDS
tool for chronic pain management that
optimize presentation of patient data
and evidence-based guidelines to
support opioid tapering. The providerfacing CDS tool will help providers
detect patients at high risk of harm from
opioids, provide personalized evidencebased guidelines to support opioid
tapering, optimize the presentation of
patient data, and reduce unnecessary
variation in clinical practice.
The provider-facing CDS tool will also
assist providers in determining if an
opioid taper is necessary for a specific
patient, aid in performing the taper, and
aid in providing follow-up and support
during the taper. The provider-facing
CDS tool is meant to accomplish three
goals: (1) Better monitor the patient’s
functional pain and opioid use, (2)
visualize patient data, and (3)
incorporate guidelines for prescribing
and tapering opioids for chronic pain.
The patient-facing CDS tool will be
used to help patients at high-risk of
harm from opioids track and manage
chronic pain and daily function to
support reduced opioid use. This goal
will be achieved through the design,
development, implementation, and
evaluation of a CDS tool that facilitates
continued patient-provider engagement.
This patient-facing CDS tool will deliver
support in ways that enhance patient
activation, education and engagement,
and collaborative decisions and actions
between patients and their care teams.
The patient-facing CDS tool should
enhance the quality of clinical
discussion between healthcare
providers and patients by allowing for
continued patient engagement outside
of the clinical setting.
This study is being conducted by
AHRQ through its contractor, MedStar
Health, pursuant to AHRQ’s statutory
authority to assist users of health
information technology focused on CDS
to promote the timely incorporation of
comparative clinical effectiveness
research into clinical practices. 42 U.S.C
299b–37(c).
Method of Collection
To achieve the goals of this project the
following data collections will be
implemented.
(1) Post-Use Survey with Providers
‘‘Evaluation Provider Survey:’’ This
evaluation includes the collection of
qualitative data through a short survey
with providers who used the providerfacing CDS tool for chronic pain
management (up to a maximum of 60).
The research team will collect insights
from providers on their experience of
implementing and using the providerfacing CDS tool for chronic pain
management. The survey will be
accessible in both online and paper
formats.
(2) Post-Use Survey with Patients
‘‘Evaluation Patient Survey:’’ This
evaluation includes the collection of
qualitative data through a short survey
with patients who used the patientfacing CDS tool for pain management
(up to a maximum of 150). The research
team will collect insights from patients
on their experience of implementing
and using patient-facing CDS. The
survey will be accessible in both online
and paper formats.
(3) Post-Use Interview with Providers
‘‘Evaluation Provider Interview:’’ This
evaluation component includes the
collection of qualitative data through an
in-depth thirty-minute interview with
providers who used the provider-facing
CDS tool for chronic pain management
(up to a maximum of 10). The research
team will collect insights from providers
on their experience of implementing
and using this provider-facing CDS tool.
(4) Post-Use Interviews with Patients
‘‘Evaluation Patient Interview:’’ This
evaluation component includes the
collection of qualitative data through an
in-depth thirty-minute interview with
patients who used the patient-facing
CDS tool for pain management (up to a
maximum of 20). The research team will
collect insights from patients on their
experience of implementing and using
the patient-facing CDS tool.
(5) Post-Use Interviews with Site
Champions ‘‘Evaluation Site Champion
Interview:’’ This evaluation component
includes the collection of qualitative
data through thirty-minute interviews
with site leads (up to a maximum of 15)
and site visits during which the research
team will collect insights from providers
and patients on their experience of
implementing and using the clinicalfacing and patient-facing CDS tools from
the perspective of the site champions.
Estimated Annual Respondent Burden
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Post-Use
Post-Use
Post-Use
Post-Use
Post-Use
Number of
responses per
respondent
Hours per
response
Total burden
hours
Survey with Providers ......................................................................
Survey with Patients ........................................................................
Interview with Providers ...................................................................
Interview with Patients .....................................................................
Interview with Site Champions ........................................................
60
150
10
20
15
1
1
1
1
1
0.25
0.25
0.5
0.5
0.5
15
37.5
5
10
7.5
Total ..........................................................................................................
255
5
2
75
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
jbell on DSKJLSW7X2PROD with NOTICES
Form name
Post-Use
Post-Use
Post-Use
Post-Use
Post-Use
Survey with Providers ......................................................................
Survey with Patients ........................................................................
Interview with Providers ...................................................................
Interview with Patients .....................................................................
Interview with Site Champions ........................................................
VerDate Sep<11>2014
17:41 Oct 14, 2020
Jkt 253001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
Total burden
hours
60
150
10
20
15
E:\FR\FM\15OCN1.SGM
15
37.5
5
10
7.5
15OCN1
Average
hourly wage
rate *
b $102.73
a 25.72
b 102.73
a 25.72
b 102.73
Total cost
burden
$1,540.95
964.50
513.65
257.20
770.48
65406
Federal Register / Vol. 85, No. 200 / Thursday, October 15, 2020 / Notices
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN—Continued
Number of
respondents
Form name
Total ..........................................................................................................
Total burden
hours
255
75
Average
hourly wage
rate *
53.95
Total cost
burden
4,046.78
* National Compensation Survey: Occupational wages in the United States May 2019, ‘‘U.S. Department of Labor, Bureau of Labor Statistics’’,
https://www.bls.gov/oes/current/oes_nat.htm#b29-0000.htm.
a Based on the mean wages for all occupations (00–0000).
b Based on the mean wages for Family Medicine Physicians (29–1215).
Request for Comments
In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501–3520,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
AHRQ’s health care research and health
care information dissemination
functions, including whether the
information will have practical utility;
(b) the accuracy of AHRQ’s estimate of
burden (including hours and costs) of
the proposed collection(s) of
information; (c) ways to enhance the
quality, utility and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: October 8, 2020.
Marquita Cullom-Stott,
Associate Director.
Proposed Project
[FR Doc. 2020–22837 Filed 10–14–20; 8:45 am]
Programmatic Information Collection
for the AHRQ Initiative To Support
Primary Care To Advance
Cardiovascular Health in States With
High Prevalence of Preventable CVD
Events
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
jbell on DSKJLSW7X2PROD with NOTICES
AGENCY:
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project
SUMMARY:
VerDate Sep<11>2014
17:41 Oct 14, 2020
‘‘Programmatic Information Collection
for the AHRQ Initiative to Support
Primary Care to Advance Cardiovascular
Health in States with High Prevalence of
Preventable CVD Events.’’
This proposed information collection
was previously published in the Federal
Register on August 5th, 2020 and
allowed 60 days for public comment.
AHRQ received no substantive
comments from members of the public.
The purpose of this notice is to allow an
additional 30 days for public comment.
DATES: Comments on this notice must be
received within 30 days of the date of
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Jkt 253001
Despite improvements in recent years,
cardiovascular disease (CVD) is a
significant national health burden and
the leading cause of death, involved in
nearly one of every three deaths.
Modifiable risk factors for CVD, such as
high blood pressure, high cholesterol,
and smoking, remain poorly controlled.
Evidence from patient-centered
outcomes research (PCOR) shows that
increasing the delivery of the ABCS of
heart health—Aspirin in high-risk
individuals, Blood pressure control,
Cholesterol management, and Smoking
cessation—can reduce risk and reduce
heart attacks and strokes.
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
In 2010, Congress established the
Patient-Centered Outcomes Research
(PCOR) Trust Fund and instructed
AHRQ to support the dissemination of
PCOR findings. In accordance with its
mandated role, AHRQ issued a Request
for Applications (RFA) entitled
Supporting Primary Care to Advance
Cardiovascular Health in States with
High Prevalence of Preventable CVD
Events. AHRQ anticipates investing up
to $18 million to support a maximum of
4 awards. Each grantee will establish a
state-level entity—known as a
Cooperative—to support primary care
improvement and run a Heart Health
Quality Improvement (QI) project. The
expected earliest start date for the grants
is December 30, 2020.
This initiative has the following goals:
1. To improve heart health and help
reduce CVD disparities by engaging
with primary care practices, and
disseminating and implementing PCOR
findings to improve care delivery.
2. To learn how to develop
sustainable state-level primary care QI
infrastructure to improve the uptake of
PCOR evidence in primary care.
3. To disseminate lessons learned,
which take into consideration the
context in which each program
operated, on how to replicate successes
and avoid challenges.
This new grant initiative is being
conducted pursuant to AHRQ’s
statutory authority to support the
agency’s dissemination of PCOR
findings. 42 U.S.C. 299b–37(a)–(c). The
information collection described in this
request is being collected under AHRQ’s
authority in 42 U.S.C. 299b–37(c),
which authorizes AHRQ to gather
feedback about the value of the PCOR
information it disseminates. The
information described in this request
will be collected by AHRQ’s contractor,
Abt Associates.
Method of Collection
To achieve the goals of this project the
following data collections will be
implemented:
1. Key informant interviews. AHRQ
will conduct phone interviews with a
variety of state-level organizations
involved in primary care support and
E:\FR\FM\15OCN1.SGM
15OCN1
]]>Agencies
[Federal Register Volume 85, Number 200 (Thursday, October 15, 2020)]
[Notices]
[Pages 65404-65406]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22837]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project ``Clinical Decision Support (CDS) for Chronic Pain
Management.''
This proposed information collection was previously published in
the Federal Register on July 14, 2020 and allowed 60 days for public
comment. AHRQ received no substantive comments. The purpose of this
notice is to allow an additional 30 days for public comment.
DATES: Comments on this notice must be received within 30 days of
publication date.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by email at
[email protected].
SUPPLEMENTARY INFORMATION:
Proposed Project
Clinical Decision Support (CDS) for Chronic Pain Management
Prescription opioid pain medication overuse, misuse, and abuse have
been a significant contributing factor in the opioid epidemic. The goal
of this project is to develop, implement, disseminate, and evaluate
clinical decision support (CDS) tools for both patients and providers
in the management of chronic pain. The CDS tools are intended to be
interoperable and publicly-shareable and will be designed to meet the
needs of patients and providers through both patient-facing and
provider-facing channels and formats.
The development and deployment of CDS tools designed to optimize
opioid dose reduction is intended to support
[[Page 65405]]
primary care providers (including physicians and advanced practice
providers) who are not pain-management specialists as well as pain
specialists as they care for patients who are at high risk of harm from
opioids. This goal will be achieved through the design, development,
implementation, and evaluation of a provider-facing CDS tool for
chronic pain management that optimize presentation of patient data and
evidence-based guidelines to support opioid tapering. The provider-
facing CDS tool will help providers detect patients at high risk of
harm from opioids, provide personalized evidence-based guidelines to
support opioid tapering, optimize the presentation of patient data, and
reduce unnecessary variation in clinical practice.
The provider-facing CDS tool will also assist providers in
determining if an opioid taper is necessary for a specific patient, aid
in performing the taper, and aid in providing follow-up and support
during the taper. The provider-facing CDS tool is meant to accomplish
three goals: (1) Better monitor the patient's functional pain and
opioid use, (2) visualize patient data, and (3) incorporate guidelines
for prescribing and tapering opioids for chronic pain.
The patient-facing CDS tool will be used to help patients at high-
risk of harm from opioids track and manage chronic pain and daily
function to support reduced opioid use. This goal will be achieved
through the design, development, implementation, and evaluation of a
CDS tool that facilitates continued patient-provider engagement. This
patient-facing CDS tool will deliver support in ways that enhance
patient activation, education and engagement, and collaborative
decisions and actions between patients and their care teams. The
patient-facing CDS tool should enhance the quality of clinical
discussion between healthcare providers and patients by allowing for
continued patient engagement outside of the clinical setting.
This study is being conducted by AHRQ through its contractor,
MedStar Health, pursuant to AHRQ's statutory authority to assist users
of health information technology focused on CDS to promote the timely
incorporation of comparative clinical effectiveness research into
clinical practices. 42 U.S.C 299b-37(c).
Method of Collection
To achieve the goals of this project the following data collections
will be implemented.
(1) Post-Use Survey with Providers ``Evaluation Provider Survey:''
This evaluation includes the collection of qualitative data through a
short survey with providers who used the provider-facing CDS tool for
chronic pain management (up to a maximum of 60). The research team will
collect insights from providers on their experience of implementing and
using the provider-facing CDS tool for chronic pain management. The
survey will be accessible in both online and paper formats.
(2) Post-Use Survey with Patients ``Evaluation Patient Survey:''
This evaluation includes the collection of qualitative data through a
short survey with patients who used the patient-facing CDS tool for
pain management (up to a maximum of 150). The research team will
collect insights from patients on their experience of implementing and
using patient-facing CDS. The survey will be accessible in both online
and paper formats.
(3) Post-Use Interview with Providers ``Evaluation Provider
Interview:'' This evaluation component includes the collection of
qualitative data through an in-depth thirty-minute interview with
providers who used the provider-facing CDS tool for chronic pain
management (up to a maximum of 10). The research team will collect
insights from providers on their experience of implementing and using
this provider-facing CDS tool.
(4) Post-Use Interviews with Patients ``Evaluation Patient
Interview:'' This evaluation component includes the collection of
qualitative data through an in-depth thirty-minute interview with
patients who used the patient-facing CDS tool for pain management (up
to a maximum of 20). The research team will collect insights from
patients on their experience of implementing and using the patient-
facing CDS tool.
(5) Post-Use Interviews with Site Champions ``Evaluation Site
Champion Interview:'' This evaluation component includes the collection
of qualitative data through thirty-minute interviews with site leads
(up to a maximum of 15) and site visits during which the research team
will collect insights from providers and patients on their experience
of implementing and using the clinical-facing and patient-facing CDS
tools from the perspective of the site champions.
Estimated Annual Respondent Burden
Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Form name Number of responses per Hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Post-Use Survey with Providers.................. 60 1 0.25 15
Post-Use Survey with Patients................... 150 1 0.25 37.5
Post-Use Interview with Providers............... 10 1 0.5 5
Post-Use Interview with Patients................ 20 1 0.5 10
Post-Use Interview with Site Champions.......... 15 1 0.5 7.5
---------------------------------------------------------------
Total....................................... 255 5 2 75
----------------------------------------------------------------------------------------------------------------
Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
Number of Total burden Average hourly Total cost
Form name respondents hours wage rate * burden
----------------------------------------------------------------------------------------------------------------
Post-Use Survey with Providers.................. 60 15 \b\ $102.73 $1,540.95
Post-Use Survey with Patients................... 150 37.5 \a\ 25.72 964.50
Post-Use Interview with Providers............... 10 5 \b\ 102.73 513.65
Post-Use Interview with Patients................ 20 10 \a\ 25.72 257.20
Post-Use Interview with Site Champions.......... 15 7.5 \b\ 102.73 770.48
---------------------------------------------------------------
[[Page 65406]]
Total....................................... 255 75 53.95 4,046.78
----------------------------------------------------------------------------------------------------------------
* National Compensation Survey: Occupational wages in the United States May 2019, ``U.S. Department of Labor,
Bureau of Labor Statistics'', https://www.bls.gov/oes/current/oes_nat.htm#b29-0000.htm.
\a\ Based on the mean wages for all occupations (00-0000).
\b\ Based on the mean wages for Family Medicine Physicians (29-1215).
Request for Comments
In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501-
3520, comments on AHRQ's information collection are requested with
regard to any of the following: (a) Whether the proposed collection of
information is necessary for the proper performance of AHRQ's health
care research and health care information dissemination functions,
including whether the information will have practical utility; (b) the
accuracy of AHRQ's estimate of burden (including hours and costs) of
the proposed collection(s) of information; (c) ways to enhance the
quality, utility and clarity of the information to be collected; and
(d) ways to minimize the burden of the collection of information upon
the respondents, including the use of automated collection techniques
or other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Dated: October 8, 2020.
Marquita Cullom-Stott,
Associate Director.
[FR Doc. 2020-22837 Filed 10-14-20; 8:45 am]
BILLING CODE 4160-90-P
